THIS IS WEEDWEEK.
BECAUSE CANNABIS NEWS MATTERS.
|
Would you appreciate a WeedWeek regional supplement with more news from
California
? Or more news about the
opioid crisis
? Sign up at the appropriate link.
Brandbuilding opportunities to appear in the newsletter with your links and social media handles start at only
$50 a month
.
|
|
LIKE US.
FOLLOW US:
ALEX HALPERIN
|
|
A Gift for Veterans
Rosenfeld discusses how cannabis helps veterans, why the Veterans Administration will eventually come around and trying cannabis for the first time at age 29.
The episode lands Monday by 4:20 p.m. Pacific.
Previous episodes:
-Episode 12 Cannabis attorney
Hilary Bricken on what's not working in the California market.
A must listen for professionals!
-Episode 10 Previously incarcerated activist and entrepreneur
Lukas Lucas on L.A.'s equity program
-Episode 7
Dr. Peter Grinspoon, Harvard Medical School, on cannabis, opioids and the medical establishment.
-Episode 4 L.A. cannabis Business attorney
Ariel Clark on what cannabis entrepreneurs need to know
|
WeedWeek Canada is a Saturday morning newsletter for professionals in the world's largest fully-legal cannabis market.
Today in WWCanada:
- Some cities want to keep the industry out, others welcome it
- Stocks jump as Trump seems OK with federalism
- The last 420 before legalization
And much more!
|
|
Senate Minority Leader Chuck Schumer (D-N.Y.)
introduced a bill to legalize REC
nationwide. “Ultimately it’s the right thing to do,” he said. Schumer is the most senior elected official in D.C. to endorse legalization.
Slate has a
good explainer
on how Schumer’s bill fits into other Democratic proposals to legalize, and the rapidly shifting political climate.
Following news from Colorado Sen. Cory Gardner (R) that President Trump supports states’ rights on marijuana, the cannabis world awaits
a promised bill from Gardner
which would codify Trump’s verbal support in law.
New York City Public Advocate Letitia Jones
supports legalization
(N.Y.Post) and said she would work with Gov. Cuomo to make it happen this year. Cuomo
released details
(Tom Angell) of New York’s legalization study.
|
|
Meanwhile, House Republicans
blocked
a measure to eliminate industry-hated tax rule 280E.
Arizona lawmakers
voted against people losing their jobs
based on a test which supposedly can determine cannabis impairment based on an AI analysis of eye motion. Even the test developer, Zxerex, conceeded the technology isn’t ready.
|
|
FDA’s staff support approval for Epidiolex, the
CBD epilepsy drug
from U.K.-based GW Pharma. The next step is for outside advisors to weigh in.
If approved it would be the first marijuana derived medicine to win FDA approval and could lead to future drugs. (Synthetic THC was approved decades ago.) The agency is expected to make its final decision on June 27.
|
|
I
n one of the highest-profile cannabis investments to date, New York firm Tiger Global, which has $22 billion under management,
led a $17M round in Green Bits,
(Business Insider) a software platform for dispensaries. Snoop Dogg’s Casa Verde Capital also participated.
For more see Fortune
.
Conservative writer Reihan Salam
wants to rein in Big Weed.
“Let’s not kid ourselves: Marijuana, Inc., thrives by catering to binge users, many of whom explicitly state that their dependence is getting in the way of their lives.”
Salam then proposes a radical alternative: “In my ideal world, Congress would establish a federal monopoly on the sale and distribution of narcotics, including but not limited to cannabis, with an eye towards minimizing the size of the black market and avoiding the aggressive marketing and lobbying that would inevitably accompany the emergence of a large for-profit industry.”
Beleagured Denver tech company MassRoots revealed a
2017 net loss of $44M
on revenue of $320,000. It’s ability to continue operations is in doubt.
|
|
Dr. Sanjay Gupta, the CNN journalist whose previous MED documentaries have been influential in swaying public opinion to favor MED, has released
Weed 4: Pot vs. Pills
.
At an addiction conference, policy experts
remain wary of MED
as an “exit drug” for opioids.
|
|
Scientific American looks at the science behind the
rat poison-tainted synthetic marijuana
-- “the spice of death” -- which has sickened more than 100 in recent weeks. Synthetic marijuana is man-made chemicals which target the same receptors in human cells and can cause severe health problems even when it isn’t tainted.
|
|
Thank You to WeedWeek's Sustaining Patrons:
|
|
Pamela Hadfield
HelloMD: The largest online community of health and wellness cannabis consumers
Spencer Vodnoy
Affiliations: CA State Bar; Board Member, Adelanto Growers Association
Critical Mind, Inc. is a Medical Cannabis Cultivation and Manufacturing Facility located in Adelanto, CA. Providing the highest quality Cannabis products. Compliance without Compromise!
|
|
The California high schoolers, now in their sixties,
credited with coining the term 4/20
, wonder if they can cash in on the green rush. Read the whole Associated Press piece, which includes the detail that 420 was added to the Oxford English Dictionary last year.
|
|
California delivery app Eaze
released a survey
of almost 5,000 customers, which shows cannabis users are more comfortable being open about their use with family and less comfortable with bosses and on social media. The San Diego Union Tribune
writes up the findings
.
The Inland Empire town of Jurupa Valley, Calif.
is in a dispute
with a marijuana church it believes is an unlicensed dispensary.
In what may be the first pro sports/cannabis partnership, soccer team Las Vegas Lights
will be sponsored
by a dispensary.
In another kind of WeedWeek, the town of Victorville Calif., was
overwhelmed with tumbleweeds
which piles up in hills on front yards and blocked some residents from leaving their homes.
An Oregon grower has developed a strain named
Markle’s Sparkle,
for his aunt Meghan who’s about to marry Prince Harry.
|
|
Want to reach a devoted audience of top cannabis professionals? Advertise in WeedWeek. Contact Adrienne Nascimento at
[email protected]
for details.
Bye,
Alex
Advertising policy: Advertisers and contributors through Patreon have no influence on WeedWeek's editorial content or on the content of articles Alex Halperin and other WeedWeek contributors write for other publications. In an effort to replicate the separation of business and editorial operations practiced at reputable news organizations, a WeedWeek salesperson will be responsible for all sales-related contact with advertisers. All advertising queries sent to editorial staff will be referred to a salesperson. In all WeedWeek material, all ads and other forms of paid content are clearly distinguishable as such. WeedWeek editorial staff does not approach potential advertisers to solicit business, and reserves the right to reject ads if they present a conflict of interest, the appearance of a conflict of interest or for any other reason. Due to our small size, editorial staff may read ads on the podcast or provide editorial input on ads after they have been purchased.
All rights reserved.
|
|
|
|
|
|
|